In this study conducted in the Makkah region, researchers observed that hairloss, mostly telogen effluvium, is a prevalent post-COVID-19 symptom, particularly among women and those with multiple health issues.
March 2024 in “International journal of research in medical sciences”
In this study, researchers reported that intradermal injections of Dr. SKS hair booster serum improved hair growth and patient satisfaction in individuals experiencing COVID-19-induced persistent telogen effluvium, with increased benefits observed over six months.
August 2024 in “Journal of Dermatology for Physician Assistants”
In this review, potential causes of COVID-19 and immunization-induced hairloss are explored, highlighting the need for early treatment and further research to clarify whether stress, viral infection, treatment medications, or nutritional deficiencies are responsible.
October 2023 in “Dermatology practical & conceptual”
This study observed that among 120 patients recovering from COVID-19, severe diffuse hairloss typically began less than two months post-infection, with the majority of patients experiencing a severe degree of hairloss and positive hair pull tests, often alongside vitamin D deficiency.
COVID and COVID vaccination can trigger hairloss, primarily telogen effluvium, due to stress and immune system activation. Proper diagnosis and addressing factors like nutrition and stress are crucial for recovery.
Finasteride users may have an increased risk of depression, anxiety, and suicidal thoughts, though some attribute these issues to hairloss itself. The link between finasteride and mental health effects is debated, with varying user experiences.
A 19-year-old in France is experiencing hairloss after COVID-19 and is using Minoxidil, considering Finasteride but facing challenges in obtaining it. Users discuss Minoxidil's effectiveness, potential issues like crystallization, and alternative products like Foligain.
A 28-year-old male experienced hairloss after COVID-19 and used Minoxidil with initial success, but later faced shedding again. He started Finasteride in February 2025, noticing improvements, but recent shedding has caused concern; his regimen includes Minoxidil, microneedling, ketoconazole shampoo, red light therapy, supplements, and a healthy lifestyle.
The user is experiencing sudden hairloss and is considering micro-needling, low-level light therapy, iron supplements, folihair, and Omega 3. They are hesitant to start finasteride, suspecting the hairloss might be due to telogen effluvium from a past COVID-19 infection.